Ashraf Daoud – General Manager, AbbVie Saudi Arabia

Ashraf Daoud, General Manager for AbbVie in Saudi Arabia, highlights how the affiliate has harnessed Allergan’s portfolio to become a top five company in the market with the objective of becoming the biopharma leader by 2022. In addition, Daoud discusses the impact that an internal Saudization strategy has had, the role of NUPCO as a centralised health care procurement buddy, and AbbVie’s initiatives to include more women in leadership positions.  
Our industry is a cornerstone of Saudi Vision because we are making big investments in talent development alongside the public sector to ensure that we raise the bar across the governmental sector
Become a PharmaBoardroom Member for free to access this content
Join the 35,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report